KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin.

N Engl J Med · 2025-Jul-17 · PMID 40513032

Panel Panel_A_GVHD-free_relapse-free_survival_GRFS_提取完成待 EXE 对齐验证

GVHD-free, relapse-free survival (GRFS)

Figure 2.. Kaplan-Meier probability curves by treatment arm for primary and secondary endpoints in the full analysis set. Panel A shows the percent of patients for the primary endpoint of GVHD-free, relapse-free survival (GRFS). Numbers at risk in each group are shown below. Panel B shows the percent of patients for the post-hoc analysis endpoint of relapse-free survival (RFS). Panel C shows the percent of patients for the secondary endpoint of overall survival (OS).

算法:legacy-0.5.0引擎:enhanced-linux
质量评分1.00
质量通过是
预期曲线2
实际曲线2
X 范围-
Y 范围-

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

当前面板没有可预览的 `curves_mapped.csv` 数据。
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0complete待验证22026-07-18T20:03:25+00:00